BMEDI
InactiveInactive; last annual accounts for fiscal year 2025. Dissolved without liquidation.
Signals
This company filed its last 7 accounts on average 31 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
History
Financials · fiscal year 2025, full schema
Click a name to add, emphasise or remove a line.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Operating income70/76A | - | - | - | €1.7m | €1.2m | ▼ 26.6% |
| Turnover70 | - | - | - | €1.7m | €1.2m | ▼ 26.8% |
| Own construction capitalised72 | - | - | - | - | €3,576 | - |
| Other operating income74 | - | - | - | €4,129 | €1,293 | ▼ 68.7% |
| Operating charges60/66A | - | - | - | €1.6m | €1.2m | ▼ 25.7% |
| Goods for resale, raw materials and consumables60 | - | - | - | €1.3m | €1.0m | ▼ 25.1% |
| Purchases600/8 | - | - | - | €1.5m | €841,939 | ▼ 43.5% |
| Change in stocks: decrease (increase)609 | - | - | - | -€148,127 | €162,539 | ▲ 210% |
| Services and other goods61 | - | - | - | €48,847 | €109,579 | ▲ 124% |
| Remuneration, social security and pensions62 | €173,465 | €139,024 | €115,288 | €128,363 | €56,399 | ▼ 56.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €8,474 | €3,418 | €1,255 | €994 | €1,000 | ▲ 0.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | €3,885 | -€13,204 | €0 | €29,137 | -€20,422 | ▼ 170% |
| Other operating charges640/8 | €557 | €11,718 | €1,842 | €4,516 | €3,752 | ▼ 16.9% |
| Gross operating margin9900 | €196,752 | €223,247 | €377,880 | - | - | - |
| Operating profit (loss)9901 | €10,372 | €82,291 | €259,495 | €101,608 | €59,230 | ▼ 41.7% |
| Financial income75/76B | €1,002 | €1,196 | €0 | €21,412 | €11,651 | ▼ 45.6% |
| Recurring financial income75 | €1,002 | €1,196 | €0 | €21,412 | €11,651 | ▼ 45.6% |
| Income from current assets751 | - | - | - | - | €235 | - |
| Other financial income752/9 | - | - | - | €21,412 | €11,416 | ▼ 46.7% |
| Financial charges65/66B | €6,421 | €801 | €11,559 | €621 | €21,295 | ▲ 3,330% |
| Recurring financial charges65 | €6,421 | €801 | €11,559 | €621 | €21,295 | ▲ 3,330% |
| Debt charges650 | - | - | - | €0 | €20,071 | - |
| Other financial charges652/9 | - | - | - | €621 | €1,224 | ▲ 97.1% |
| Profit (loss) for the period before taxes9903 | €4,953 | €82,686 | €247,936 | €122,400 | €49,586 | ▼ 59.5% |
| Income taxes67/77 | €174 | €24,922 | €66,965 | €31,601 | €12,905 | ▼ 59.2% |
| Taxes670/3 | - | - | - | €31,601 | €12,905 | ▼ 59.2% |
| Profit (loss) for the period9904 | €4,779 | €57,763 | €180,971 | €90,799 | €36,681 | ▼ 59.6% |
| Profit (loss) for the period to be appropriated9905 | €4,779 | €57,763 | €180,971 | €90,799 | €36,681 | ▼ 59.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €721,444 | €611,540 | €696,288 | €1.2m | €826,717 | ▼ 28.6% |
| Fixed assets21/28 | €6,312 | €5,388 | €2,755 | €1,761 | €4,337 | ▲ 146% |
| Intangible fixed assets21 | - | - | - | - | €3,570 | - |
| Tangible fixed assets22/27 | €6,021 | €5,097 | €2,755 | €1,761 | €767 | ▼ 56.4% |
| Furniture and vehicles24 | €6,021 | €5,097 | €2,755 | €1,761 | €767 | ▼ 56.4% |
| Financial fixed assets28 | €291 | €291 | €0 | - | - | - |
| Current assets29/58 | €715,132 | €606,152 | €693,533 | €1.2m | €822,380 | ▼ 28.9% |
| Stocks and contracts in progress3 | €126,382 | €112,543 | €148,029 | €265,062 | €122,945 | ▼ 53.6% |
| Stocks30/36 | €126,382 | €112,543 | €148,029 | €265,062 | €122,945 | ▼ 53.6% |
| Goods purchased for resale34 | - | - | - | €265,062 | €122,945 | ▼ 53.6% |
| Amounts receivable within one year40/41 | €439,004 | €155,577 | €514,108 | €867,056 | €660,269 | ▼ 23.8% |
| Trade receivables40 | €433,335 | €155,524 | €502,411 | €828,657 | €603,775 | ▼ 27.1% |
| Other amounts receivable41 | €5,669 | €53 | €11,696 | €38,399 | €56,494 | ▲ 47.1% |
| Cash at bank and in hand54/58 | €149,746 | €338,033 | €29,848 | €24,148 | €38,930 | ▲ 61.2% |
| Deferred charges and accrued income490/1 | - | - | €1,549 | €0 | €235 | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €721,444 | €611,540 | €696,288 | €1.2m | €826,717 | ▼ 28.6% |
| Equity10/15 | €192,874 | €250,637 | €231,608 | €322,407 | €359,088 | ▲ 11.4% |
| Contributions10/11 | €14,000 | €14,000 | €14,000 | €14,000 | €14,000 | = |
| Reserves13 | €1,860 | €1,860 | €182,831 | €308,407 | €345,088 | ▲ 11.9% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €0 | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €0 | - | - | - |
| Distributable reserves133 | - | - | €182,831 | €308,407 | €345,088 | ▲ 11.9% |
| Profit (loss) carried forward14 | €177,014 | €234,777 | €34,777 | €0 | - | - |
| Amounts payable17/49 | €528,570 | €360,903 | €464,680 | €835,621 | €467,629 | ▼ 44.0% |
| Amounts payable within one year42/48 | €528,570 | €360,903 | €464,680 | €835,621 | €416,382 | ▼ 50.2% |
| Trade debts44 | €399,596 | €215,751 | €151,773 | €119,034 | €140,477 | ▲ 18.0% |
| Suppliers440/4 | €399,596 | €215,751 | €151,773 | €119,034 | €140,477 | ▲ 18.0% |
| Advances received on contracts in progress46 | €108 | €3,090 | €0 | - | - | - |
| Taxes, remuneration and social security45 | €78,865 | €92,063 | €102,907 | €80,840 | €4,163 | ▼ 94.9% |
| Taxes450/3 | €29,069 | €38,217 | €89,367 | €77,219 | €0 | ▼ 100% |
| Remuneration and social security454/9 | €49,796 | €53,845 | €13,540 | €3,621 | €4,163 | ▲ 15.0% |
| Other amounts payable47/48 | €50,000 | €50,000 | €210,000 | €635,747 | €271,742 | ▼ 57.3% |
| Accrued charges and deferred income492/3 | - | - | - | - | €51,247 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €4,779 | €57,763 | €180,971 | €90,799 | €36,681 | ▼ 59.6% |
| + Depreciation and write-downs630 | €8,474 | €3,418 | €1,255 | €994 | €1,000 | ▲ 0.7% |
| Operating cash flow (approximation) | €13,253 | €61,181 | €182,226 | €91,793 | €37,682 | ▼ 58.9% |
| Investment in fixed assets (approximation) | - | -€2,494 | €1,378 | €0 | -€3,576 | - |
| Change in cash | - | €188,287 | -€308,185 | -€5,699 | €14,781 | ▲ 359% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
12-02
State Gazette act
Restructuring · End & cessationMerger · Dissolution · Capital6 facts ▸
- General meeting, 30-12-2025
- Merger, absorption, 46
- Dissolution, 2025-12-31T23:59:59
- Capital, €76.000
- Share issue, 14.000,00 EUR
- Power of attorney, FISCAAL ADVIESKANTOOR
Show earlier events
About the unread acts
Of the 11 Belgian State Gazette acts we know for this company, 1 has been read. The other 10 have not been read yet: what they contain is neither established nor disproved here.
Structure & network
Owners and holdings
1 ownerChain of control
Highest known parent: Bobbie Pharmaceutical Services. The sources do not say who stands above it.
Owners 1
- VERGELparentSourceown accounts 2025100%
Holdings 0
The accounts to 31-12-2025 list no holdings, and no other source names one.
According to the 2025 annual accounts of BMEDI and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Acquisitions and mergers
1 transactionCapital and shareholders
- 12-02-2026 Capital stated in the act · 76,000 EUR · 296 shares